CME Supplements

Diagnosing and Managing Tardive Dyskinesia

This activity is supported by an independent educational grant from Neurocrine Biosciences.

 

Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications.

Click here to read the supplement and earn free CME/CE credits by learning about TD and evidence based treatments.


Educational Objectives

  • Discuss the diagnosis, differential diagnosis and risk factors for TD
  • Identify the prevalence of TD with antipsychotics
  • Use the AIMS examination
  • Review the evidence and non-evidence based treatments for TD
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering
    the emergence of new FDA approved treatments for TD

Click here to read the supplement.

Recommended Reading

AMA urges change after dramatic increase in illicit opioid fatalities
MDedge Psychiatry
COVID-19 fears would keep most Hispanics with stroke, MI symptoms home
MDedge Psychiatry
Diary of a rheumatologist who briefly became a COVID hospitalist
MDedge Psychiatry
NFL’s only physician player opts out of 2020 season over COVID
MDedge Psychiatry
Physician recruitment drops by 30% because of pandemic
MDedge Psychiatry
MIS-C is a serious immune-mediated response to COVID-19 infection
MDedge Psychiatry
Pandemic-related stress causing health issues in many Americans
MDedge Psychiatry
Flu and pneumonia vaccination tied to lower dementia risk
MDedge Psychiatry
A better tau blood test for diagnosing Alzheimer’s disease?
MDedge Psychiatry
Microbiome research ‘opening doors’ to new Alzheimer’s disease treatments
MDedge Psychiatry